[Oral contraception, glucid metabolism and monitoring criteria].
D001157:Arterial Occlusive Diseases; D001695:Biology; D002241:Carbohydrates; D002319:Cardiovascular System; D002560:Cerebrovascular Circulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003920:Diabetes Mellitus; D004194:Disease; D004702:Endocrine Glands; D005193:Family Planning Services; D005947:Glucose; D008660:Metabolism; D010827:Physiology; D011154:Population Characteristics; D045167:Progesterone Congeners; D014652:Vascular Diseases; D014680:Veins
D002241:Carbohydrates; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D045167:Progesterone Congeners; D005947:Glucose
Arterial Occlusive Diseases; Biology; Carbohydrate Metabolic Effects; Cardiovascular Effects; Cerebrovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--contraindications; Diabetes Mellitus; Diseases; Endocrine Effects; Family Planning; Glucose Metabolism Effects; Metabolic Effects; Oral Contraceptives; Oral Contraceptives, Combined--contraindications; Oral Contraceptives, Low-dose; Oral Contraceptives, Phasic; Physiology; Population At Risk; Progestins, Low-dose; Vascular Diseases; Venous Engorgement
Contraception orale, metabolisme glucidique et criteres de surveillance.